Abstract
Contrast-induced nephropathy is a major cause of morbidity and mortality associated with percutaneous coronary intervention. Recently, several reports have shown that N-acetylcysteine is effective to reduce the occurrence of contrast-induced nephropathy, but some reports could not confirm this. Different dosages of N-acetylcysteine may lead the conflicting results, and thus we examined the effect of N-acetylcysteine at >3600 mg in total dosage on serum creatinine levels after coronary intervention.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
